Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal

Small Molecules for the Treatment of Long-COVID-Related Vascular Damage and Abnormal Blood Clotting: A Patent-Based Appraisal

People affected by COVID-19 are exposed to, among others, abnormal clotting and endothelial dysfunction, which may result in deep vein thrombosis, cerebrovascular disorders, and ischemic and non-ischemic heart diseases, to mention a few. Treatments for COVID-19 include antiplatelet (e.g., aspirin, c...

Full description

Bibliographic Details
Main Authors: Francesco Samarelli, Giovanni Graziano, Nicola Gambacorta, Elisabetta Anna Graps, Francesco Leonetti, Orazio Nicolotti, Cosimo Damiano Altomare
Format: Article
Language:English
Published: MDPI AG 2024-03-01
Series:Viruses
Subjects:
long COVID
vascular issues
ramatroban
caspase inhibitors
procyanidins
Online Access:https://www.mdpi.com/1999-4915/16/3/450

Internet

https://www.mdpi.com/1999-4915/16/3/450

Similar Items